Biggest News Aggregation in the World
📰 Vector Engineering News

Vector Engineering News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Vector Engineering. Real-time updates on events, politics, business and more.

MeiraGTx Reports Second Quarter 2023 Financial and Operational Results

Phase 3 LUMEOS clinical trial of botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for the treatment of X-linked retinitis pigmentosa (XLRP) enrollment target has now been surpassedAnnounced positive clinical data from the completed AQUAx Phase 1 study of AAV2-hAQP1 for the treatment of grade 2/3 radiation-induced xerostomia (RIX), showing bilaterally treated participants reaching normal levels of whole saliva flow rate by 2 months post-treatment and persisting through the final Month 12
City Of United Kingdom United States Jason Braco Association For Research Lifesci Communications
Source: yahoo.com

MeiraGTx Reports Fourth Quarter and Full Year 2022 Financial and Operational Results

14.03.2023 - -   Announced positive clinical data from AQUAx AAV-hAQP1 Phase 1 trial for treatment of Grade 2/3 Radiation-Induced Xerostomia in December 2022 -   Announced positive top-line data from the MGT009 Phase 1/2 clinical study demonstrating safety and ...
United States United Kingdom City Of Jason Braco Botaretigene Sparoparvovec American Academy Of Ophthalmology Annual Meeting

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science